The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography: Findings of the American cancer society national prostate cancer detection project
β Scribed by R. Joseph Babaian; Curtis Mettlin; Robert Kane; Gerald P. Murphy; Fred Lee; Joseph R. Drago; Arthur Chesley
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 539 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Project is a prospective, multidisciplinary, and multicenter trial to assess the potential for early detection of prostate cancer by transrectal ultrasonography (TRUS), digital rectal examination (DRE), and serum prostate-specific antigen assay (PSA). By November 1990, 2805 men between the ages of 5
Over a 4% year period, 1,940 asymptomatic men were entered in a prostate cancer detection program consisting of digital rectal examination (DRE), prostate-specific antigen (PSA), and transrectal prostate ultrasound (TRUS). Four hundred and sixteen biopsies were performed resulting in the diagnosis o
In a study population, can digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate specific antigen (PSA) (monoclonal) effectively detect the majority of clinically relevant cancer? If this is possible, the remaining patients could then be considered for chemopreventive protoco
The American Cancer Society National Prostate Cancer Detection Project (ACS-NPCDP) is a multidisciplinary, multicenter effort to assess the feasibility of early prostate cancer detection by digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate specific antigen (PSA) assay. By
## BACKGROUND. The American Cancer Society National Prostate Cancer Detection Proj-(James H. Gilbaugh, Jr., M.D.); Urology Clinic ect (ACS-NPCDP) was established in 1987. The experience of the ACS-NPCDP demonof Yakima, Yakima, Washington (Mark Uhlman, strates the yield and impact of periodic exami